This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
January 31, 2012 5:00 pm ET
Timothy M. Ring - Chairman, Chief Executive Officer and Chairman of Executive Committee
John H. Weiland - President, Chief Operating Officer and Director
Todd C. Schermerhorn - Chief Financial Officer and Senior Vice President
John A. DeFord - Senior Vice President of Science Technology & Clinical Affairs
Lawrence S. Keusch - Morgan Keegan & Company, Inc., Research Division
Brooks E. West - Piper Jaffray Companies, Research Division
Jonathan J. Palmer - Credit Agricole Securities (USA) Inc., Research Division
David R. Lewis - Morgan Stanley, Research Division
Matthew Taylor - Barclays Capital, Research Division
Michael Matson - Mizuho Securities USA Inc., Research Division
Michael N. Weinstein - JP Morgan Chase & Co, Research Division
Miroslava Minkova - Leerink Swann LLC, Research Division
Kristen M. Stewart - Deutsche Bank AG, Research Division
Topher Orr - Goldman Sachs Group Inc., Research Division
Joanne K. Wuensch - BMO Capital Markets U.S.
Robert A. Hopkins - BofA Merrill Lynch, Research Division
Jason Wittes - Caris & Company, Inc., Research Division
Matthew O'Brien - William Blair & Company L.L.C., Research Division
Anthony Petrone - Jefferies & Company, Inc., Research Division
Suraj Kalia - Rodman & Renshaw, LLC, Research Division
Gregory Hertz - Citigroup Inc, Research Division
Robert M. Goldman - CL King & Associates, Inc.
Jayson T. Bedford - Raymond James & Associates, Inc., Research Division
Ladies and gentlemen, thank you for standing by. Welcome to the CR Bard Inc. Fourth Quarter 2011 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded and will be available for future on-demand replay through the Bard website.
Today's presentation will be hosted by Timothy M. Ring, Chairman and Chief Executive Officer; along with John H. Weiland, President and Chief Operating Officer; and Todd C. Schermerhorn, Senior Vice President of Science Technology and Clinical Affairs; and Todd W. Garner, Vice President, Investor Relations.